Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

Completed · Not applicable

Conditions studied: Cardiovascular Disease and Lipoprotein(a)

In brief

The study is conducted to improve knowledge about the epidemiology of Lipoprotein(a) in patients with established cardiovascular disease (CVD).

Key facts

Study ID

NCT03887520

Run by

Novartis Pharmaceuticals

People needed

49001

Starts

2018-11-27

Expected to finish

2021-07-30

Last updated by the study team

2022-01-28

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed informed consent
• Established CVD defined as one of the following:
• History of a myocardial infarction (MI) ≥3 months and ≤10 years before the study visit
• History of ischemic stroke ≥ 3 months and ≤ 10 years before the study visit
• Symptomatic PAD (intermitted claudication with ankle-brachial index ≤0.90 and/or lower limb amputation or re-vascularization due to lower limb ischemia

You may not qualify if…

• Patients currently enrolled in clinical studies with investigational drugs

Where it is running

• Novartis Investigative Site — Birmingham, Alabama, United States
• Novartis Investigative Site — Huntsville, Alabama, United States
• Novartis Investigative Site — Mobile, Alabama, United States
• Novartis Investigative Site — Cottonwood, Arizona, United States
• Novartis Investigative Site — Mesa, Arizona, United States
• Novartis Investigative Site — Surprise, Arizona, United States
• Novartis Investigative Site — Tucson, Arizona, United States
• Novartis Investigative Site — Little Rock, Arkansas, United States
• Novartis Investigative Site — Beverly Hills, California, United States
• Novartis Investigative Site — Concord, California, United States
• Novartis Investigative Site — Covina, California, United States
• Novartis Investigative Site — Fresno, California, United States
• Novartis Investigative Site — Huntington Beach, California, United States
• Novartis Investigative Site — Long Beach, California, United States
• Novartis Investigative Site — Los Angeles, California, United States
• Novartis Investigative Site — Los Angeles, California, United States
• Novartis Investigative Site — Northridge, California, United States
• Novartis Investigative Site — Orange, California, United States
• Novartis Investigative Site — Orangevale, California, United States
• Novartis Investigative Site — San Diego, California, United States
• Novartis Investigative Site — San Francisco, California, United States
• Novartis Investigative Site — Santa Ana, California, United States
• Novartis Investigative Site — Stanford, California, United States
• Novartis Investigative Site — Stockton, California, United States
• Novartis Investigative Site — Andalusia, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.